Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-09-24

FDA Approved: BUPRENORPHINE HYDROCHLORIDE — Original Application (PAI Holdings, LLC dba Pharmaceutical Associates, Inc. and dba PAI Pharma)

View source ↗

Summary

FDA approved a generic buprenorphine hydrochloride product under an Original Application (ANDA 090622) from PAI Holdings/PAI Pharma. This marks the approval of …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Buprenorphine Hydrochloride (Buprenorphine hydrochloride)

Snippet

ORIG AP for BUPRENORPHINE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE)